Pharmacologic and Pharmacodynamic Equivalence of 2 Formulations of Orlistat
Author:
Affiliation:
1. GSK Consumer Healthcare; Parsippany NJ USA
Funder
GSK Consumer Healthcare
Publisher
Wiley
Subject
Pharmacology (medical),Pharmaceutical Science
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.457/fullpdf
Reference23 articles.
1. World Health Organisation. Obesity and overweight fact sheet 2016 http://www.who.int/mediacentre/factsheets/fs311/en/
2. AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society;Jensen;Circulation,2014
3. European guidelines for obesity management in adults;Yumuk;Obesity Facts,2015
4. Orlistat for the management of overweight individuals and obesity: a review of potential for the 60-mg, over-the-counter dosage;Anderson;Expert Opin Pharmacother.,2007
5. Xenical capsules approval letter NDA 20-766 1999 https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1999/20766ltr.pdf
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sample Size Determination and Study Design Impact on Dose-Scale Pharmacodynamic Bioequivalence: a Case Study Using Orlistat;The AAPS Journal;2024-07-03
2. Advancements in the management of obesity: a review of current evidence and emerging therapies;Expert Review of Endocrinology & Metabolism;2024-04-29
3. Therapeutic advances in obesity management: an overview of the therapeutic interventions;Frontiers in Endocrinology;2024-04-23
4. Polycystic ovary syndrome and metabolic syndrome: possible ways to correct metabolic disorders;Experimental and Clinical Gastroenterology;2024-03-26
5. Tisochrysis lutea F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling;Marine Drugs;2023-05-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3